The fifth shot｜Appointments can be made from 12.16 Hong Kong government: Whether the new crown vaccination must be regularized next year

The government announced today (7th) that starting from this Friday (9th), people aged 18 or above can make an appointment to receive the Fubitai bivalent vaccine as the third dose, and from the 16th of this month, four doses, or Persons aged 18 or above who have received the third dose and who have recovered from infection can make an appointment for the fifth dose. They can choose Sinovac, Fubitai original virus strain or Fubitai bivalent vaccine.

The government also stated that it will refer to the latest scientific evidence and expert advice next year to review whether a new round of new crown vaccination plans is needed, including whether new crown vaccinations need to be regularized, the priority groups recommended to be vaccinated under the plan, and through the public Vaccination arrangements provided by the private medical sector for the general public and specific groups such as the elderly, medical staff, residents and staff of institutions, school teachers and students, etc.

▼On September 22, Lu Chongmao and officials received the fourth dose of Sinovac vaccine and influenza vaccine▼

+3

From Friday, you can make an appointment with Fubitai bivalent vaccine

A government spokesman said that from 9 a.m. on Friday (9th), citizens can make an appointment to receive the bivalent vaccine of Fubitai through the system.

Before the appointment system is updated, citizens aged 18 or above can also request to be vaccinated with Fubitai bivalent vaccine on the spot when they are vaccinated.

A government spokesman pointed out that in response to expert advice, the government is enhancing the functions of the vaccination record system and the online appointment system. Citizens can make appointments online from 9:00 am on the 16th and start receiving the latest dose of vaccine on the same day.

▼September 30, the first day of application of the vaccine pass to 5 years old▼

The SWD has sent letters to various institutions to introduce the bivalent vaccine of Fubitai

The government spokesperson emphasized that next year, it will refer to the latest scientific evidence and expert advice to review whether it is necessary to launch a new round of COVID-19 vaccination plan, including whether the new crown vaccination needs to be regularized, and the priority groups recommended to be vaccinated under the plan, As well as vaccination arrangements for the general public and specific groups such as the elderly, medical staff, residents and staff of institutions, school teachers and students, etc. through the public and private medical sectors.

In response to the latest recommendations from experts, the Social Welfare Department has sent letters to the homes to introduce the bivalent vaccine of Fubita to their families and residents, and to explain that residents can choose to receive the fifth dose of vaccine as needed.

If residents wish to choose to receive the bivalent vaccine or the fifth dose of Fubita vaccine, they can express their willingness to vaccinate to the residence, and the government will arrange an outreach medical team to visit and vaccinate as soon as possible.

▼November 9th, BB version of Fubitai started today Parents take their children to Children's Hospital for injection▼

New crown vaccine drug manufacturers can apply for registration in Hong Kong

The spokesman added that in view of the fact that the data proving the safety and effectiveness of the new crown vaccine is sufficient, drug manufacturers of the new crown vaccine, which were previously only approved for emergency use, can apply in Hong Kong under the Pharmacy and Poisons Regulations (Cap. 138A) register.

If approved, registered drug manufacturers can sell and supply the vaccine directly to healthcare professionals, making it available in the private market like seasonal flu vaccines or human papillomavirus vaccines Normalize.

New Ten Measures in the Mainland｜Jin Dongyan, an expert from the University of Hong Kong: Hong Kong can refer to the rapid test to replace the strong inspection of the vaccine.

12.6｜An increase of 9952 confirmed cases involving 725 imported vaccines with a record high of 16 deaths｜Yuan Guoyong's team developed a nasal spray new crown vaccine that was approved for emergency use in the mainland.

12.5｜Add 9508 confirmed cases. Hong Kong University developed a nasal vaccine. The mainland took the lead in using it. A total of 11 children were infected and passed away.

12.4｜16 more patients passed away in 51 places including Ying Ri Wan in Tsuen Wan and Park Island in Ma Wan.